Compound 11 showed reduced expression of the cancer-related gene mTOR and had a good predicted drug-like profile.
Molecules · 7 authors, 4 centres
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
Compound 11 showed reduced expression of the cancer-related gene mTOR and had a good predicted drug-like profile.
A series of novel 2-phenylamino-3-acyl-1,4-naphthoquinones were synthesized and evaluated for antiproliferative activity in vitro against DU-145 (prostate), MCF-7 (breast), and T24 (bladder) human cancer cell lines. In silico analyses suggested compound 11 has favorable drug-like properties. In DU-145 cells, compound 11 significantly reduced the expression of the mTOR gene, which is involved in tumor metabolism, and molecular docking indicated it has good affinity for the mTOR protein. The authors propose compound 11 inhibits cancer cell proliferation through reduced mTOR expression and activity.